Kestra Medical Technologies (KMTS) reported a preliminary fiscal Q2 operating loss Monday of $31.6 million to $32 million, widening from a loss of $19.1 million a year earlier.

Analysts surveyed by FactSet expect a loss of $31.6 million.

Revenue for the quarter ended Oct. 31 is expected to be $22.2 million to $22.6 million, up from $14.7 million a year earlier.

Analysts polled by FactSet expect revenue of $20.7 million.

Shares of the company were up 1.2% in recent Monday premarket activity.